TrianglePUBLICATIONS · 11675332
Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2001 Nov 1
- First author
- Leblond V
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Leblond V
- type
- Author
- name
- Lévy V
- type
- Author
- name
- Maloisel F
- type
- Author
- name
- Cazin B
- type
- Author
- name
- Fermand JP
- type
- Author
- name
- Harousseau JL
- type
- Author
- name
- Remenieras L
- type
- Author
- name
- Porcher R
- type
- Author
- name
- Gardembas M
- type
- Author
- name
- Marit G
- type
- Author
- name
- Deconinck E
- type
- Author
- name
- Desablens B
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Leblond V
- type
- Author
- name
- Lévy V
- type
- Author
- name
- Maloisel F
- type
- Author
- name
- Cazin B
- type
- Author
- name
- Fermand JP
- type
- Author
- name
- Harousseau JL
- type
- Author
- name
- Remenieras L
- type
- Author
- name
- Porcher R
- type
- Author
- name
- Gardembas M
- type
- Author
- name
- Marit G
- type
- Author
- name
- Deconinck E
- type
- Author
- name
- Desablens B
- type
- Author
- bibliography ids
- nci-bib-947a25af1b5bd4a08d30a4f7
- book metadata
- content sha256
- 5cbfcd2573f699b7cdadf9e315255688156f9f8a1b969fcf546c7da51653d0de
- document type
- citation
- dois
- 10.1182/blood.v98.9.2640
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:11675332
- immutable id
- pubmed:11675332@5cbfcd2573f699b7cdadf9e315255688156f9f8a1b969fcf546c7da51653d0de
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 9
- name
- Blood
- nlm unique id
- 7603509
- pages
- 2640-4
- volume
- 98
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 11675332
- provenance
- batch id
- bc1299bcdb6a81bdf655
- provider
- NCBI PubMed ESummary
- record sha256
- 7dbaa8de234dafb8481e2967f583d2d74b32edaef0cb233443128ae5d85de336
- response sha256
- c4d63e9a162706394efcc7d20cd416503379c383137f167684654db2709afc4f
- retrieved at
- 2026-09-09T23:45:42.126507+00:00
- publication date
- display
- 2001 Nov 1
- precision
- day
- year
- 2001
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease.
Preserved source evidence · Independent clinical review pending · Not medical advice